BACKGROUND AND OBJECTIVES: End-stage renal disease (ESRD) patients are at high risk for tuberculosis (TB). IFN-gamma release assays that assess immune responses to specific TB antigens offer potential advantages over tuberculin skin testing (TST) in screening such patients for Mycobacterium tuberculosis infection. This study sought to determine whether IFN-gamma release assay results are more closely associated with recent TB exposure than TST results. DESIGN, SETTING, PARTICIPANTS, AND MEASURES: Prospective cohort investigation of patients at a hemodialysis center with a smear-positive case of TB. Patients without a history of TB underwent initial and repeat testing with TST, and with the IFN-gamma assays QuantiFERON-TB Gold (QFT-G) and ELISPOT test. Outcome measures included the prevalence of positive test results, identification of factors associated with positive results, and test result discordance. RESULTS: A total of 100 (47% foreign born; median age, 55 yr; age range, 18 to 83 yr) of 124 eligible patients were enrolled. Twenty-six persons had positive TST results, 21 had positive QFT-G results, and 27 had positive ELISPOT results. Patients with TB case contact were likely to have a positive QFT-G result (P = 0.02) and ELISPOT results (P = 0.04), whereas TB case contact was not associated with positive TST results (P = 0.7). Positive TST results were associated with foreign birth (P = 0.04) and having had a TST in the previous year (P = 0.04). CONCLUSIONS: Positive IFN-gamma assay results were more closely associated with recent TB exposure than were positive TST results. QFT-G and ELISPOT might offer a better method for detecting TB infection in ESRD patients.
BACKGROUND AND OBJECTIVES: End-stage renal disease (ESRD) patients are at high risk for tuberculosis (TB). IFN-gamma release assays that assess immune responses to specific TB antigens offer potential advantages over tuberculin skin testing (TST) in screening such patients for Mycobacterium tuberculosis infection. This study sought to determine whether IFN-gamma release assay results are more closely associated with recent TB exposure than TST results. DESIGN, SETTING, PARTICIPANTS, AND MEASURES: Prospective cohort investigation of patients at a hemodialysis center with a smear-positive case of TB. Patients without a history of TB underwent initial and repeat testing with TST, and with the IFN-gamma assays QuantiFERON-TB Gold (QFT-G) and ELISPOT test. Outcome measures included the prevalence of positive test results, identification of factors associated with positive results, and test result discordance. RESULTS: A total of 100 (47% foreign born; median age, 55 yr; age range, 18 to 83 yr) of 124 eligible patients were enrolled. Twenty-six persons had positive TST results, 21 had positive QFT-G results, and 27 had positive ELISPOT results. Patients with TB case contact were likely to have a positive QFT-G result (P = 0.02) and ELISPOT results (P = 0.04), whereas TB case contact was not associated with positive TST results (P = 0.7). Positive TST results were associated with foreign birth (P = 0.04) and having had a TST in the previous year (P = 0.04). CONCLUSIONS: Positive IFN-gamma assay results were more closely associated with recent TB exposure than were positive TST results. QFT-G and ELISPOT might offer a better method for detecting TB infection in ESRDpatients.
Authors: Homayoun Shams; Stephen E Weis; Peter Klucar; Ajit Lalvani; Patrick K Moonan; Janice M Pogoda; Katie Ewer; Peter F Barnes Journal: Am J Respir Crit Care Med Date: 2005-08-04 Impact factor: 21.405
Authors: P D Johnson; R L Stuart; M L Grayson; D Olden; A Clancy; P Ravn; P Andersen; W J Britton; J S Rothel Journal: Clin Diagn Lab Immunol Date: 1999-11
Authors: D M Lewinsohn; L Zhu; V J Madison; D C Dillon; S P Fling; S G Reed; K H Grabstein; M R Alderson Journal: J Immunol Date: 2001-01-01 Impact factor: 5.422
Authors: S Sasaki; T Akiba; M Suenaga; S Tomura; N Yoshiyama; S Nakagawa; T Shoji; T Sasaoka; J Takeuchi Journal: Nephron Date: 1979 Impact factor: 2.847
Authors: Gerald H Mazurek; Stephen E Weis; Patrick K Moonan; Charles L Daley; John Bernardo; Alfred A Lardizabal; Randall R Reves; Sean R Toney; Laura J Daniels; Philip A LoBue Journal: Clin Infect Dis Date: 2007-08-24 Impact factor: 9.079
Authors: Luca Richeldi; Katie Ewer; Monica Losi; David M Hansell; Pietro Roversi; Leonardo M Fabbri; Ajit Lalvani Journal: Ann Intern Med Date: 2004-05-04 Impact factor: 25.391
Authors: Laura Passalent; Kamran Khan; Robert Richardson; Jun Wang; Helen Dedier; Michael Gardam Journal: Clin J Am Soc Nephrol Date: 2006-10-18 Impact factor: 8.237
Authors: J Grant; J Jastrzebski; J Johnston; A Stefanovic; J Jastrabesky; K Elwood; D Roscoe; R Balshaw; E Bryce Journal: Can J Infect Dis Med Microbiol Date: 2012 Impact factor: 2.471
Authors: Richard D Powell; William C Whitworth; John Bernardo; Patrick K Moonan; Gerald H Mazurek Journal: PLoS One Date: 2011-06-08 Impact factor: 3.240
Authors: Sanjay K Agarwal; Urvashi B Singh; Sabahat H Zaidi; Sanjay Gupta; Ravinder M Pandey Journal: Indian J Med Res Date: 2015-04 Impact factor: 2.375